U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07256119) titled 'Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients' on Nov. 20.
Brief Summary: the purpose of this study is to evaluate the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Study Start Date: Aug. 06, 2024
Study Type: INTERVENTIONAL
Condition:
Prevention
Intervention:
DIETARY_SUPPLEMENT: Alpha Lipoic Acid
alpha lipoic acid 300 mg three times daily under the trade name of THIOTACID manufactured by EVAPHARMA.
Recruitment Status: RECRUITING
Sponsor: Ain Shams University
Information provided by (Responsible Party): Rana mohamed, Ain Shams U...